Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "University of California Law"


2 mentions found


As President-elect Donald Trump’s choice to lead the CDC, Dave Weldon, a former congressman from Florida and a physician, is positioned as an important anti-vaccine ally for Robert F. Kennedy Jr., Trump's pick for health secretary. The CDC is responsible for tracking and responding to infectious diseases, developing vaccine guidelines, collecting and analyzing health data and managing public health emergencies. The CDC provides vaccine recommendations for the public, including the pediatric vaccine schedule, which is followed by schools and parents. “This puts CDC, and HHS, in the driver’s seat for determining vaccine recommendations going forward,” she said. As HHS secretary, Kennedy could replace members of the ACIP with anti-vaccine advocates who make recommendations that the CDC approves, Reiss speculated.
Persons: Donald Trump’s, Dave Weldon, Robert F, Kennedy Jr, Weldon, Kennedy, , Dorit Reiss, , Donald Trump, Tim Shortt, Reuters Kennedy, Weldon ‘, Trump, wouldn’t “, Jennifer Kates, Kates, Reiss, doesn’t, ” Reiss, Dr, Peter Hotez, “ We’ve, that’s, ” Hotez, we’ve, “ Who’s Organizations: Centers for Disease Control, of, CDC, Department of Health, Human Services, Senate, U.S, HHS, University of California Law, Trump, Florida Today, Reuters, NBC News, Global Health, HIV, Democratic, Affordable, Texas Children’s Hospital, Vaccine Development, World Health Organization Locations: Florida, U.S, of Florida, Francisco, Melbourne, Fla, Texas, pertussis
Patients with private health insurance aren't likely to see a drop in costs from the negotiations. Longo said the price-setting provisions will drive research and investment away from treatment options for Medicare patients. If drug companies won't come to the negotiating table to lower drug prices paid by private insurers, those insurers could take the companies' drugs off their lists of covered medications. Or, if private insurance companies don't negotiate drug prices down for their patients, patients in some cases could seek out different insurance. "These are not full solutions, but they are the beginning of cracks in the facade" of drug companies' constant price hikes, Feldman said.
Persons: Biden, Juliette Cubanski, Jeffrey Davis, Davis, Richard Frank, , Nicole Longo, Longo, it's, — aren't, Robin Feldman, Feldman, Cuban's Organizations: Medicare, Healthcare, Morning, Centers, Services, Congressional, McDermott, Consulting, Brookings Schaeffer Initiative, Health, Pharmaceutical Research, Manufacturers of America, PhRMA, University of California Law School, Costco, Pharmaceutical Locations: Lower
Total: 2